Recent Advances in Prostate Cancer Treatment and Drug Discovery

Recent Advances in Prostate Cancer Treatment and Drug Discovery

Novel drugs, drug sequences and combinations have improved the outcome of prostate cancer in recent years. The latest approvals include abiraterone acetate, enzalutamide and apalutamide which target androgen receptor (AR) signaling, radium-223 dichloride for reduction of bone metastases, sipuleucel-...

Full description

Bibliographic Details
Main Authors: Ekaterina Nevedomskaya, Simon J. Baumgart, Bernard Haendler
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:International Journal of Molecular Sciences
Subjects:
prostate cancer
androgen receptor
PI3K pathway
DNA repair
“omics” technologies
Online Access:http://www.mdpi.com/1422-0067/19/5/1359

Internet

http://www.mdpi.com/1422-0067/19/5/1359

Similar Items